Skip to search.
 TSX Up 0.11% TSX Ventures Down 0.30%

Agenus Inc. (AGEN)

-NasdaqCM
6.05 Down 0.03(0.49%) Aug 23, 4:00PM EDT
Prev Close:6.08
Open:6.12
Bid:6.00 x 700
Ask:6.21 x 300
1y Target Est:9.75
Beta:2.11861
Earnings Date:Oct 25 - Oct 31 (Est.)
Day's Range:6.03 - 6.16
52wk Range:2.61 - 7.45
Volume:854,276
Avg Vol (3m):1,013,770
Market Cap:526.33M
P/E (ttm):N/A
EPS (ttm):-1.04
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
AGENDown 0.49%526.33M
ABPI 0.00%N/A

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):19.54
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-1.27
Quarterly EPS Est (Sep-16) :-0.29
Mean Recommendation*:1.6
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Agenus Inc., an immuno-oncology company, focuses on the discovery and development of treatments that engage the body’s immune system for patients suffering with cancer. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback